Peer Review reports
From: Alectinib treatment improves photodynamic therapy in cancer cell lines of different origin
Original Submission | ||
---|---|---|
4 Aug 2020 | Submitted | Original manuscript |
8 Sep 2020 | Reviewed | Reviewer Report |
12 Jan 2021 | Reviewed | Reviewer Report |
3 Feb 2021 | Reviewed | Reviewer Report - Cherie Ann Kruger |
30 Apr 2021 | Author responded | Author comments - Bernhard Gillissen |
Resubmission - Version 2 | ||
30 Apr 2021 | Submitted | Manuscript version 2 |
12 May 2021 | Reviewed | Reviewer Report |
13 May 2021 | Reviewed | Reviewer Report - Cherie Ann Kruger |
28 May 2021 | Reviewed | Reviewer Report |
1 Jul 2021 | Author responded | Author comments - Bernhard Gillissen |
Resubmission - Version 3 | ||
1 Jul 2021 | Submitted | Manuscript version 3 |
20 Jul 2021 | Author responded | Author comments - Bernhard Gillissen |
Resubmission - Version 4 | ||
20 Jul 2021 | Submitted | Manuscript version 4 |
2 Aug 2021 | Author responded | Author comments - Bernhard Gillissen |
Resubmission - Version 5 | ||
2 Aug 2021 | Submitted | Manuscript version 5 |
Publishing | ||
6 Aug 2021 | Editorially accepted | |
30 Aug 2021 | Article published | 10.1186/s12885-021-08667-x |
You can find further information about peer review here.